To amend the Federal Food, Drug, and Cosmetic Act to reauthorize the authority to grant certain exemptions, and for other purposes.
12/29/2022, 11:48 PMSummary of Bill HR 7679
Bill 117 hr 7679, also known as the "FDA Exemptions Reauthorization Act," aims to amend the Federal Food, Drug, and Cosmetic Act in order to extend the authority to grant certain exemptions. The bill seeks to reauthorize the ability to grant exemptions for specific products or substances that may not meet all the requirements outlined in the Act.The main purpose of this bill is to ensure that the Food and Drug Administration (FDA) has the flexibility to grant exemptions when necessary, in order to promote innovation and access to new products while still maintaining safety and efficacy standards. This reauthorization is important for industries that rely on exemptions to bring new products to market, such as medical devices or certain food additives.
Overall, the bill is focused on balancing the need for regulatory oversight with the need for flexibility and innovation in the marketplace. It is intended to support the FDA in its mission to protect public health while also fostering growth and development in industries regulated by the Act.
Congressional Summary of HR 7679
This bill reauthorizes through FY2027 (1) the Humanitarian Device Exemption Program (a specialized regulatory pathway for medical devices used to treat or diagnose diseases or conditions that affect no more than 8,000 individuals), and (2) the Pediatric Device Consortia Grants Program (a program that supports the development of medical devices for pediatric patients through nonprofit consortia).
Read the Full Bill
Current Status of Bill HR 7679
Bill HR 7679 is currently in the status of Bill Introduced since May 6, 2022. Bill HR 7679 was introduced during Congress 117 and was introduced to the House on May 6, 2022. Bill HR 7679's most recent activity was Referred to the House Committee on Energy and Commerce. as of May 6, 2022Bipartisan Support of Bill HR 7679
Total Number of Sponsors
1Democrat Sponsors
1Republican Sponsors
0Unaffiliated Sponsors
0Total Number of Cosponsors
2Democrat Cosponsors
0Republican Cosponsors
2Unaffiliated Cosponsors
0Policy Area and Potential Impact of Bill HR 7679
Primary Policy Focus
HealthAlternate Title(s) of Bill HR 7679
To amend the Federal Food, Drug, and Cosmetic Act to reauthorize the authority to grant certain exemptions, and for other purposes.To amend the Federal Food, Drug, and Cosmetic Act to reauthorize the authority to grant certain exemptions, and for other purposes.Comments
Most relevant
Sponsors and Cosponsors of HR 7679
Latest Bills
PROTECT Students Act of 2025
Bill S 994April 4, 2025
A bill to amend the Agriculture Improvement Act of 2018 to reauthorize the feral swine eradication and control pilot program, and for other purposes.
Bill S 1207April 4, 2025
SBA Fraud Enforcement Extension Act
Bill S 1199April 4, 2025
A bill to amend the Internal Revenue Code of 1986 to exclude from gross income certain federally subsidized loan repayments for dental school faculty.
Bill S 1080April 4, 2025
A bill to establish a contracting preference for public buildings that use innovative wood products in the construction of those buildings, and for other purposes.
Bill S 1094April 4, 2025
A bill to amend the Internal Revenue Code of 1986 to exclude from gross income capital gains from the sale of certain farmland property which are reinvested in individual retirement plans.
Bill S 930April 4, 2025
A bill to provide that the Federal Communications Commission may not prevent a State or Federal correctional facility from utilizing jamming equipment, and for other purposes.
Bill S 1137April 4, 2025
A bill to require the heads of Federal agencies to submit to Congress an annual report regarding official time authorized under title 5, United States Code, and for other purposes.
Bill S 1170April 4, 2025
Mining Waste, Fraud, and Abuse Prevention Act of 2025
Bill S 859April 4, 2025
A joint resolution disapproving the rule submitted by the Bureau of Consumer Financial Protection relating to "Defining Larger Participants of a Market for General-Use Digital Consumer Payment Applications".
Bill SJRES 28April 4, 2025
FDASLA Act of 2022
Bill S 4348December 29, 2022